Healthcare systems face critical challenges from AI oversight gaps and staffing crises, while advances in women's health diagnostics and vaccine approvals offer new patient protection strategies.

Clinicians and patients are increasingly deferring to AI outputs without independent judgment at HLTH Europe 2026, creating a 'blind trust' problem that puts patient safety at risk by undermining critical clinical decision-making.

Scotland's cancer centres report dangerous treatment delays caused by staff shortages, with the Royal College of Radiologists warning the situation will worsen significantly by 2030 without intervention.

AI and multimodal data collection are being leveraged to close the gender health gap, addressing issues like cardiac misdiagnosis in women and the documented 8-year average wait for endometriosis diagnosis.

FDA approves expanded pneumococcal vaccine indication for high-risk children and teenagers aged 2-17 years with chronic medical conditions, broadening immunization protection.

Monoclonal antibody-based therapies can interfere with transfusion testing results, potentially leading to dangerous misinterpretations and requiring careful medical coordination in patient care.

High-dose omega-3 supplements reach the brain but fail to provide cognitive benefits in older adults at high-risk for Alzheimer's disease, according to new clinical trial evidence.

Protein and creatine supplements have transitioned from niche fitness products to mainstream consumption, raising questions about appropriate dosing, use among GLP-1 patients, and neurological benefits.

Physicians are adopting AI tools at the point of care, reshaping clinical workflows and diagnostic processes across healthcare settings.